HANISH ARNOLD C (CIK 1233253) reported 10 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-09-02). Recent activity: Buy DCOY (3,000 shares), Buy OMER (5,000 shares), Sell OMER (5,000 shares), Buy OMER (2,500 shares), Buy OMER (7,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Decoy Therapeutics Inc. (DCOY) | Director | Buy | 3,000 | $0 |
| 2026-08-28 | OMEROS CORP (OMER) | Director | Buy | 5,000 | $79,050 |
| 2026-08-28 | OMEROS CORP (OMER) | Director | Sell | 5,000 | $92,632 |
| 2026-08-28 | OMEROS CORP (OMER) | Director | Buy | 2,500 | $39,525 |
| 2026-08-28 | OMEROS CORP (OMER) | Director | Buy | 7,500 | $109,950 |
| 2026-08-28 | OMEROS CORP (OMER) | Director | Sell | 5,000 | $94,381 |
| 2026-08-28 | OMEROS CORP (OMER) | Director | Sell | 5,000 | $95,080 |
| 2026-01-02 | Salarius Pharmaceuticals, Inc. (SLRX) | Director | Sell | 15 | $10 |
| 2026-01-02 | Salarius Pharmaceuticals, Inc. (SLRX) | Director | Sell | 12 | $8 |
| 2025-11-24 | Salarius Pharmaceuticals, Inc. (SLRX) | Director | Buy | 5,000 | $3,750 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02